FGF2 and small cell lung carcinoma: The relevance of our findings to cancer is further supported by the fact that similar results to those in HEK293 cells were obtained in small-cell lung cancer cells (Figures 1 and 4A–D) where FGF-2 drives cytotoxic drug-resistance.